9. Cardiovascular Disease and Risk Management

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)

James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial

Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638

Glucagon-like peptide 1 in health and disease

Andersen, A., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0016-2 · Cited by 543

Diabetes and lipid metabolism

Athyros, V. G., Doumas, M. N., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., & Karagiannis, A. I. (2018) · HORMONES · doi:10.1007/s42000-018-0014-8 · Cited by 384

Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity

Fisher, D. P., Johnson, E., Haneuse, S., Arterburn, D., Coleman, K. J., O’Connor, P. J., O’Brien, R., Bogart, A., Theis, M. K., Anau, J., et al. (2018) · JAMA · doi:10.1001/jama.2018.14619 · Cited by 305

Lifestyle Strategies for Risk Factor Reduction, Prevention, and Treatment of Cardiovascular Disease

Rippe, J. M. (2018) · American Journal of Lifestyle Medicine · doi:10.1177/1559827618812395 · Cited by 362

Semaglutide improves postprandial glucose and lipid metabolism, and delays first‐hour gastric emptying in subjects with obesity

Hjerpsted, J. B., Flint, A., Brooks, A., Axelsen, M. B., Kvist, T., & Blundell, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13120 · Cited by 245

Epidemiology in diabetes mellitus and cardiovascular disease

Fan, W. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000116 · Cited by 249

Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus

Liu, G., Li, Y., Hu, Y., Zong, G., Li, S., Rimm, E. B., Hu, F. B., Manson, J. E., Rexrode, K. M., Shin, H. J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.027 · Cited by 221

Smoking and diabetes: dangerous liaisons and confusing relationships

Campagna, D., Alamo, A., Pino, A. D., Russo, C., Calogero, A. E., Purrello, F., & Polosa, R. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0482-2 · Cited by 246

Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial

Frias, J., Virdi, N., Raja, P., Kim, Y., Savage, G., & Osterberg, L. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7833 · Cited by 213

Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes ( REWIND ) trial on the cardiovascular effects of dulaglutide

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Díaz, R., Lakshmanan, M. C., Pais, P. S., Probstfield, J. L., Riddle, M. C., Rydén, L., Xavier, D., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13028 · Cited by 185

Unhealthy Dietary Habits and Obesity: The Major Risk Factors Beyond Non-Communicable Diseases in the Eastern Mediterranean Region

Al‐Jawaldeh, A., & Abbass, M. M. S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.817808 · Cited by 225

Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014)

Bucholz, E. M., Rodday, A. M., Kolor, K., Khoury, M. J., & de Ferranti, S. D. (2018) · Circulation · doi:10.1161/circulationaha.117.032321 · Cited by 157

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–2014

Burrows, N. R., HORA, I. A., Geiss, L. S., Gregg, E. W., & Albright, A. L. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643a2 · Cited by 166

Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study

Wong, N. D., Zhao, Y., Patel, R. J., Patao, C., Malik, S., Bertoni, A. G., Correa, A., Folsom, A. R., Kachroo, S., Mukherjee, J., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2439 · Cited by 153

Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes

Wang, T., Lu, J., Su, Q., Chen, Y., Bi, Y., Mu, Y., Chen, L., Hu, R., Tang, X., Yu, X., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2499 · Cited by 145

Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial

Leiter, L. A., Cariou, B., Müller‐Wieland, D., Colhoun, H. M., Prato, S. D., Tinahones, F. J., Ray, K. K., Bujas‐Bobanovic, M., Domenger, C., Mandel, J., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13114 · Cited by 138

Prevention of Cardiovascular Disease

Reamy, B. V., Williams, P. M., & Kuckel, D. P. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.11.003 · Cited by 111

Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial

Ray, K. K., Leiter, L. A., Müller‐Wieland, D., Cariou, B., Colhoun, H. M., Henry, R. R., Tinahones, F. J., Bujas‐Bobanovic, M., Domenger, C., Letierce, A., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13257 · Cited by 104

Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies

Schernthaner, G., & Schernthaner-Reiter, M. H. (2018) · Diabetologia · doi:10.1007/s00125-018-4547-9 · Cited by 96

JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases

Yamagishi, M., Tamaki, N., Akasaka, T., Ikeda, T., Ueshima, K., Uemura, S., Otsuji, Y., Kihara, Y., Kimura, K., Kimura, T., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-19-1131 · Cited by 100

Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus—Rationale, design, and baseline characteristics

Green, J. B., Hernandez, A. F., D’Agostino, R. B., Granger, C. B., Janmohamed, S. G., Jones, N. P., Leiter, L. A., Noronha, D., Russell, R., Sigmon, K. N., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.03.030 · Cited by 91

Impact of Lifestyle Interventions Targeting Healthy Diet, Physical Activity, and Weight Loss on Asthma in Adults: What Is the Evidence?

Nyenhuis, S. M., Dixon, A. E., & Ma, J. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.10.026 · Cited by 95

Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes

Liu, G., Li, Y., Pan, A., Hu, Y., Chen, S., Qian, F., Rimm, E. B., Manson, J. E., Stampfer, M. J., Giatsidis, G., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.52239 · Cited by 94

Current Management of Patients With Acquired Solitary Kidney

Tantisattamo, E., Dafoe, D. C., Reddy, U. G., Ichii, H., Rhee, C. M., Streja, E., Landman, J., & Kalantar‐Zadeh, K. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.07.001 · Cited by 85

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population

Li, S., Peng, Y., Wang, X., Qian, Y., Xiang, P., Wade, S. W., Guo, H., López, J. A. G., Herzog, C. A., & Handelsman, Y. (2019) · Clinical Cardiology · doi:10.1002/clc.23160 · Cited by 75

How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies

Humphrey, T. J. L., Davids, M. R., Chothia, M., Pecoits‐Filho, R., Pollock, C. A., & James, G. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab243 · Cited by 80

Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension

Stergiou, G. S., Brunström, M., MacDonald, T. M., Kyriakoulis, K. G., Bursztyn, M., Khan, N. A., Bakris, G. L., Κόλλιας, Α., Menti, A., Muntner, P., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003240 · Cited by 71

Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies

Jiao, J., Liu, G., Shin, H. J., Hu, F. B., Rimm, E. B., Rexrode, K. M., Manson, J. E., Zong, G., & Sun, Q. (2019) · BMJ · doi:10.1136/bmj.l4009 · Cited by 71

Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action

Zhu, P., Pan, X., Sheng, L., Chen, H., & Pan, A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0903-2 · Cited by 77

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice

Sarayani, A., Mashayekhi, M., Nosrati, M., Jahangard‐Rafsanjani, Z., Javadi, M., Saadat, N., Najafi, S., & Gholami, K. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0593-0 · Cited by 72

Impact of a goal setting and decision support telephone coaching intervention on diet, psychosocial, and decision outcomes among people with type 2 diabetes

Swoboda, C. M., Miller, C. K., & Wills, C. E. (2017) · Patient Education and Counseling · doi:10.1016/j.pec.2017.02.007 · Cited by 72

The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.

Weng, W., Tian, Y., Kong, S. X., Ganguly, R., Hersloev, M., Brett, J., & Hobbs, T. (2019) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.76 · Cited by 65

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

Shah, H., Gao, H., Morieri, M. L., SKUPIEN, J. K., Marvel, S. W., Paré, G., Mannino, G. C., Buranasupkajorn, P., Mendonça, C., Hastings, T., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0285 · Cited by 59

Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease

Poręba, M., Rostoff, P., Siniarski, A., Mostowik, M., Gołębiowska-Wiatrak, R., Nessler, J., Undas, A., & Gajos, G. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0672-5 · Cited by 60

Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues

Khoo, T., & Chinoy, H. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103468 · Cited by 60

Key Points from the Updated Guidelines on Exercise and Diabetes

Colberg, S. R. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00033 · Cited by 60

Future perspectives of the pharmacological management of diabetic dyslipidemia

Patti, A. M., Giglio, R. V., Παπάνας, Ν., Rizzo, M., & Rizvi, A. A. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1567328 · Cited by 55

Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment–Related Cardiovascular Toxicity

Dent, S. F., Kikuchi, R., Kondapalli, L., Ismail-Khan, R. R., Brezden‐Masley, C., Barac, A., & Fradley, M. G. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_286019 · Cited by 59

The connection between hypertension and diabetes and their role in heart and kidney disease development

Hezam, A. A. M., Shaghdar, H. B. M., & Chen, L. (2024) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_470_23 · Cited by 65

Patients with diabetes without significant angiographic coronary artery disease have the same risk of myocardial infarction as patients without diabetes in a real-world population receiving appropriate prophylactic treatment

Olesen, K. K. W., Madsen, M., Egholm, G., Thim, T., Jensen, L. O., Raungaard, B., Bøtker, H. E., Sørensen, H. T., & Maeng, M. (2017) · Diabetes Care · doi:10.2337/dc16-2388 · Cited by 51

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

Pantalone, K. M., Misra‐Hebert, A. D., Hobbs, T. M., Ji, X., Kong, S. X., Milinovich, A., Weng, W., Bauman, J. M., Ganguly, R., Burguera, B. G., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0699-7 · Cited by 51

Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease

Olesen, K. K. W., Madsen, M., Gyldenkerne, C., Thrane, P. G., Würtz, M., Thim, T., Jensen, L. O., Eikelboom, J. W., Bøtker, H. E., Sørensen, H. T., et al. (2019) · Stroke · doi:10.1161/strokeaha.119.026099 · Cited by 56

Type 2 diabetes in general practice in Norway 2005–2014: moderate improvements in risk factor control but still major gaps in complication screening

Bakke, Å., Cooper, J. G., Thue, G., Skeie, S., Carlsen, S., Dalen, I., Løvaas, K. F., Madsen, T. V., Oord, E. R., Berg, T. J., et al. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000459 · Cited by 49

Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial

Sheikh, O., Hei, A. V., Battisha, A., Hammad, T., Pham, S. V., & CHILTON, R. J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0887-0 · Cited by 52

Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension

Hanipah, Z. N., Punchai, S., McCullough, A. J., Dasarathy, S., Brethauer, S. A., Aminian, A., & Schauer, P. R. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3372-z · Cited by 48

European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)

Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43

Cardiovascular disease prevention strategies for type 2 diabetes mellitus

Katsiki, N., Purrello, F., Tsioufis, C. P., & Mikhailidis, D. P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1351946 · Cited by 42

Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

Hernández, M., López‐Cano, C., Real, J., Valls, J., de Victoria, E. O.-M., Vázquez, F., Rubinat, E., Granado-Casas, M., Alonso, N., Molí, T., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0576-9 · Cited by 41

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes

Rotroff, D. M., Pijut, S. S., Marvel, S. W., Jack, J. R., Havener, T. M., Pujol, A., Schlüter, A., Graf, G. A., Ginsberg, H. N., Shah, H., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.798 · Cited by 39

Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial

Morieri, M. L., Gao, H., Pigeyre, M., Shah, H., Sjaarda, J., Mendonça, C., Hastings, T., Buranasupkajorn, P., Motsinger‐Reif, A. A., Rotroff, D. M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0709 · Cited by 39

Effect of purslane on blood lipids and glucose: A systematic review and meta‐analysis of randomized controlled trials

Hadi, A., Pourmasoumi, M., Najafgholizadeh, A., Kafeshani, M., & Sahebkar, A. (2018) · Phytotherapy Research · doi:10.1002/ptr.6203 · Cited by 39

The healthy Nordic diet for blood glucose control: a systematic review and meta-analysis of randomized controlled clinical trials

Zimorovat, A., Mohammadi, M., Ramezani‐Jolfaie, N., & Salehi‐Abargouei, A. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01369-8 · Cited by 37

Dyslipidemia and its associated factors among adult diabetes outpatients in West Shewa zone public hospitals, Ethiopia

Abdissa, D., & Hirpa, D. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02489-w · Cited by 36

Reversing the tide — diagnosis and prevention of T2DM in populations of African descent

Utumatwishima, J. N., Chung, S. T., Bentley, A. R., Udahogora, M., & Sumner, A. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.127 · Cited by 36

Co-occurrence of Cardiometabolic Disease Risk Factors: Unhealthy Eating, Tobacco, Alcohol, Sedentary Lifestyle and Socioeconomic Aspects

Eduard, M.-S., Parra‐Flores, J., & Rodríguez-Fernández, A. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190213 · Cited by 37

Relationship Between Number of Multiple Risk Factors and Coronary Artery Disease Risk With and Without Diabetes Mellitus

Yamada, M. H., Fujihara, K., OSAWA, T., Yamamoto, M., Kaneko, M., Kitazawa, M., Matsubayashi, Y., Yamada, T., YAMANAKA, N., Seida, H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00168 · Cited by 34

Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes

Bauduceau, B., Floch, J. P. L., Halimi, S., Verny, C., Doucet, J., & Intergroup, T. S. (2017) · Diabetes Care · doi:10.2337/dc17-1437 · Cited by 35

Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: a 15-year cohort study

Wu, H.-Y., Peng, C.-L., Chen, P.-C., Chiang, C.-K., Chang, C.-J., Huang, J.-W., Peng, Y.-S., Tu, Y.-K., Chu, T.-S., Hung, K.-Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177654 · Cited by 33

The effects of quinoa seed supplementation on cardiovascular risk factors: A systematic review and meta‐analysis of controlled clinical trials

Karimian, J., Abedi, S., Shirinbakhshmasoleh, M., Moodi, F., Moodi, V., & Ghavami, A. (2020) · Phytotherapy Research · doi:10.1002/ptr.6901 · Cited by 33

The effect of polymorphisms (174G> C and 572C> G) on the Interleukin-6 gene in coronary artery disease: a systematic review and meta-analysis

Salari, N., Mansouri, K., Far, A. H., Ghasemi, H., Mohammadi, M., Jalali, R., & Vaisi-Raygani, A. (2021) · Genes and Environment · doi:10.1186/s41021-021-00172-8 · Cited by 32

Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus

Chorepsima, S., Eleftheriadou, I., Tentolouris, A., Moyssakis, I. E., Protogerou, A. D., Kokkinos, A. D., Sfikakis, P. P., & Tentolouris, N. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0178-2 · Cited by 32

The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes

Gonna, H., & Ray, K. K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13691 · Cited by 30

Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence

Angiolillo, D. J., & Capodanno, D. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.022 · Cited by 29

Impact of different dietary approaches on glycemic control and cardiovascular risk factors in patients with type 2 diabetes: a protocol for a systematic review and network meta-analysis

Schwingshackl, L., Chaimani, A., HOFFMANN, G. E., Schwedhelm, C., & Boeing, H. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0455-1 · Cited by 30

A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients

Zhang, Y., Li, Y., Dong, Y., Wu, Y., Bian, R., Ji-hu, L., & Ji, L. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13675 · Cited by 25

Genetic Variation in Kruppel like Factor 15 Is Associated with Left Ventricular Hypertrophy in Patients with Type 2 Diabetes: Discovery and Replication Cohorts

Patel, S. K., Wai, B., Lang, C. C., Levin, D., Palmer, C. N. A., Parry, H., Velkoska, E., Harrap, S. B., Srivastava, P., & Burrell, L. M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.036 · Cited by 27

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors

Cavaiola, T. S., & Pettus, J. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s154602 · Cited by 27

What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?

Solini, A., & Grossman, E. (2016) · Diabetes Care · doi:10.2337/dcs15-3027 · Cited by 27

ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels

Jun, J. E., Choi, Y. J., Lee, Y., Kim, D. J., Park, S. W., Huh, B. W., Lee, E. J., Jee, S. H., Hur, K. Y., Choi, S. H., et al. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.396 · Cited by 26

Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes

Bahtiyar, G., Pujals-Kury, J., & Sacerdote, A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1043-z · Cited by 24

Aspirin for the primary prevention of cardiovascular disease: latest evidence

Capodanno, D., Ingala, S., Calderone, D., & Angiolillo, D. J. (2019) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1651199 · Cited by 24

Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice

Wang, S., Yu, T., Tsai, F., Weston, C. J., Lin, M., Hung, C., Kao, H., Li, Y., Solé, M., Unzeta, M., et al. (2018) · Translational research · doi:10.1016/j.trsl.2018.03.001 · Cited by 24

Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes

Gatwood, J. D., Chisholm‐Burns, M. A., Davis, R. L., Thomas, F., Potukuchi, P. K., Hung, A. M., McFarland, M. S., & Kovesdy, C. P. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3665-x · Cited by 24

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

Weng, W., Tian, Y., Kong, S. X., Ganguly, R., Hersloev, M., Brett, J., & Hobbs, T. M. (2020) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-019-0090-y · Cited by 26

Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population

Woo, Y. C., Lee, C., Fong, C. H.-Y., Tso, A. W. K., Cheung, B. M. Y., & Lam, K. S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184840 · Cited by 24

Influences on Diabetes Self-Management Education Participation in a Low-Income, Spanish-Speaking, Latino Population

Testerman, J., & Chase, D. A. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0046 · Cited by 36

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study

Karlsson, S. A., Hero, C., Svensson, A., Franzén, S., Miftaraj, M., Guðbjörnsdóttir, S., Eeg‐Olofsson, K., Eliasson, B., & Sundell, K. A. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020309 · Cited by 22

Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors: Shaping the future after the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (FOURIER) trial

Katsiki, N., Athyros, V. G., Mikhailidis, D. P., & Mantzoros, C. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.007 · Cited by 21

Factors associated with diabetic nephropathy in children, adolescents, and adults with type 1 diabetes

Huang, C., Ting, W., Lo, F., Tsai, J.-D., Sun, F., Chan, C.-I., Chiang, Y.-T., Lin, C., Cheng, B.-W., Wu, Y., et al. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.09.015 · Cited by 22

Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros

Makrilakis, K., & Liatis, S. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8927473 · Cited by 21

The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes

Pasquel, F. J., Gregg, E. W., & Ali, M. K. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.11.001 · Cited by 20

Associations between glycaemic control and activation of the renin-angiotensin-aldosterone system in participants with type 2 diabetes mellitus and hypertension

Griffin, T. P., Wall, D., Browne, G. A., Dennedy, M. C., & O’Shea, P. M. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217728964 · Cited by 21

Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines

Antza, C., Doundoulakis, I., Stabouli, S., & Kotsis, V. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0236-x · Cited by 18

Type 2 Diabetes

Samson, S. L., & Garber, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95795-7 · Cited by 18

Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease

King, A., RAJPURA, J. R., Liang, Y. M., Paprocki, Y., & Uzoigwe, C. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2125259 · Cited by 18

Intensive versus standard multifactorial cardiovascular risk factor control in screen‐detected type 2 diabetes: 5‐year and longer‐term modelled outcomes of the ADDITION‐Leicester study

Webb, D. R., Dales, J., Zaccardi, F., Hill, S., Moore, C., Farooqi, A. M., Griffin, S. J., Davies, M. J., & Khunti, K. K. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3111 · Cited by 16

Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: a one-year retrospective matched cohort study

Mottalib, A., Tomah, S., Hafida, S., Elseaidy, T., Kasetty, M., Ashrafzadeh, S., & Hamdy, O. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13478 · Cited by 15

Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease

Wang, B., Zhao, Z., Liu, S., Wang, S., Chen, Y., Xu, Y. H., Xu, M., Wang, W., Ning, G., Li, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108873 · Cited by 15

Prevalence of nephropathy in Indian children and youth with type 1 diabetes mellitus

Karguppikar, M. B., Oza, C. M., Shah, N., Khadilkar, V. V., Gondhalekar, K. M., & Khadilkar, A. V. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0644 · Cited by 15

Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with the Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to Predict Diabetic Proteinuria

Aziz, K. M. A. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180924114041 · Cited by 16

Laparoscopic loop duodenaljejunal bypass with sleeve gastrectomy in type 2 diabetic patients

Hanipah, Z. N., Hsin, M.-C., Liu, C.-C., & Huang, C. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.01.016 · Cited by 16

A Mobile Health-Based Disease Management Program Improves Blood Pressure in People With Multiple Lifestyle-Related Diseases at Risk of Developing Vascular Disease ― A Retrospective Observational Study ―

Kanai, M., Toda, T., Yamamoto, K., Akimoto, M., & Hagiwara, Y. (2022) · Circulation Reports · doi:10.1253/circrep.cr-22-0024 · Cited by 14

Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States

Hunt, B., McConnachie, C. C., Gamble, C. L., & Dang‐Tan, T. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1347793 · Cited by 14

Dyslipidaemia in the elderly: to treat or not to treat?

Katsiki, N., Kolovou, G. D., Pérez‐Martínez, P., & Mikhailidis, D. P. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1425138 · Cited by 14

Predicting the risk of atherosclerotic cardiovascular disease (ASCVD) in Pakistani population

Hassan, K., Mohydin, B. S., Fawwad, A., Waris, N., Iqbal, S., & Jawaid, M. (2018) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2018.04.002 · Cited by 14

Simultaneous angiotensin receptor blockade and glucagon‐like peptide‐1 receptor activation ameliorate albuminuria in obese insulin‐resistant rats

Rodríguez, R., Escobedo, B., Lee, A. Y., Thorwald, M. A., Godoy-Lugo, J. A., Nakano, D., Nishiyama, A., Parkes, D. G., & Ortiz, R. M. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13206 · Cited by 14

Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life

Springer, S. P., Mor, M. K., Sileanu, F. E., Zhao, X., Aspinall, S. L., Ersek, M. T., Niznik, J. D., Hanlon, J. T., Hunnicutt, J. N., Gellad, W. F., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16346 · Cited by 15

Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

Karlsson, S. A., Franzén, S., Svensson, A., Miftaraj, M., Eliasson, B., & Sundell, K. A. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3707-4 · Cited by 13

Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults

Wang, J., Wang, Z., Guo, F., Zhang, Y., Ji, H., Chen, G., Wan, Q., Yan, L., Wang, G., Qin, Y., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab609 · Cited by 13

Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study

Fundoiano-Hershcovitz, ‪., Bacher, D., Ritholz, M. D., Horwitz, D. L., Manejwala, O., & Goldstein, P. (2022) · Journal of Medical Internet Research · doi:10.2196/32923 · Cited by 14

8. Cardiovascular Disease and Risk Management

American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s011 · Cited by 239

Section 10: Cardiovascular Disease and Risk Management

(2025) · Clinical Diabetes · doi:10.2337/cd25-a010 · Cited by 1

Chapter 17: Cardiovascular Disease and Risk Management

(2022) · American Diabetes Association eBooks · doi:10.2337/9781580408172.ch17

Managing Cardiovascular Disease and Events in the Patient with Diabetes

Wyne, K. L. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-0273-4.50020-5 · Cited by 1

Topics in Cardiovascular Disease and Diabetes

Bloomgarden, Z. T. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1624 · Cited by 4